InSilico Medicine Cayman TopCo (HKG:3696)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
42.06
-1.44 (-3.31%)
Jul 30, 2026, 4:08 PM HKT

HKG:3696 Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
56.2456.2485.8351.1830.15
Revenue Growth
4.92%-34.48%67.71%69.77%-
Gross Profit
45.8545.8577.5838.5719.11
Operating Income
-59.99-59.99-37.33-83.73-80.12
Net Income
-352.32-352.32-17.1-211.64-221.83
Earnings Per Share
-4.48-4.48-0.24-3.13-3.31
EPS Growth
-----

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
United States
31.5731.5779.3845.919.37
Chinese Mainland
17.5317.532.143.459.24
Kingdom of Saudi Arabia
1.821.821.9--
France
1.541.54---
Hong Kong
1.051.050.030.0210.01
Japan
0.620.620.70.440.21
United Kingdom
0.480.480.150.050.06
Denmark
0.360.360.60.27-
United Arab Emirates
0.280.28-0.01-
Korea
0.220.220.280.050
Germany
0.080.080.030.090.33
Switzerland
0.050.050.240.660.77
Taiwan
0.010.010.110.030.08
Others
0.620.620.260.210.08
Total
56.2456.2485.8351.1830.15

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
447.27447.27125.94177.18207.88
Total Debt
5.965.962.562.193.22
Net Cash (Debt)
441.31441.31123.38174.99204.66
Net Cash Growth
114.56%257.68%-29.49%-14.50%-
Net Cash Per Share
5.615.611.722.593.05

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-76.77-76.77-57.4-29.58-47.52
Capital Expenditures
-2.86-2.86-0.84-2.56-10.98
Free Cash Flow
-79.62-79.62-58.25-32.14-58.5
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
81.52%81.52%90.38%75.36%63.39%
Operating Margin
-106.66%-106.66%-43.49%-163.60%-265.75%
Pretax Margin
-626.36%-626.36%-19.73%-413.36%-735.78%
Profit Margin
-626.46%-626.46%-19.92%-413.52%-735.82%
FCF Margin
-141.58%-141.58%-67.86%-62.79%-194.03%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
55.0047.15---